Why Set & Save?
Just click "Add to Set & Save" when placing items in your cart.
DS Labs is First With Astressin-B
Spectral.F7 is the first hair treatment to incorporate astressin-B, a peptide that is very long and complex, with a 30+ amino-acid sequence, and includes a cyclo-lactam bridge. Astressin-B contains some unusual amino acids, and unlike virtually all peptides in cosmetic use, it is particularly difficult to synthesize. This advancement in the art and science of hair solidifies DS Laboratories' reputation for developing cutting-edge technologies and bringing them to the customers first.
Who should use Spectral.F7
Men and women concerned about thinning hair and overall hair health can combine Spectral.F7 with existing therapies such as Spectral.DNC® for maximum benefit, or they can use the products as an effective stand-alone treatment.
Spectral.F7 features astressin-B, a peptide (protein fragment) with a very complex sequence newly discovered to block the receptors for corticotropin-releasing factor (CRF), involved in the stress response. An in-vivo murine study investigated whether CRF blockage might influence hair growth when stress hormones are over-expressed, and it showed a promising new mechanism of action on atrophic hair follicles.